Ayushman Bharat to cost Rs 5k cr this year

The government’s mega health insurance scheme Ayushman Bharat — National Health Protection Mission (AB-NHPM) may cost the exchequer around Rs 5,000 crore this year because of the time taken to rollout the scheme. The scheme will cost Rs 10,000 crore when its rolled out across India next year.

While this year there will be 8 crore beneficiaries, the target is to cover 10 crore by FY 20.

The government also sees a limited role for private sector insurers in AB-NHPM and the first preference will be given to implementation by the states in assurance mode, said a senior government official aware of the development.

The other options are insurance mode or a combination mixed mode. Assurance mode covers the entire gamut of health protection from sanitation and prevention to care during an illness. Insurance mode, usually, only covers expenses related to hospitalisation.

In the first year, out of the total expenditure of Rs 5,000 crore, the central government may bear the burden of around Rs 3,000 crore which will increase to almost Rs 7,000 crore in FY20.

AB-NHPM aims to provide a benefit cover of Rs 5 lakh per family per year. The target beneficiaries of the proposed scheme will be families belonging to the poor and vulnerable population based on Socio-Economic Caste Census (SECC) database.

Ayushman Bharat to cost Rs 5k cr this year
So far, 20 states have agreed to implement the scheme and have signed a memorandum of understanding (MoU) with the centre government.

The scheme will subsume the on-going centrally sponsored schemes — Rashtriya Swasthya Bima Yojana (RSBY) and the Senior Citizen Health Insurance Scheme (SCHIS).

The states will need a State Health Agency (SHA) to implement the scheme. They will also have the option to use an existing trust as an SHA. “If the states want to implement the scheme in insurance mode, they may limit the bidding only among public sector companies,” said the official quoted above, adding that if an open bid is invited and the lowest bidder is a private sector firm, then a public sector company will be given a chance to meet the lowest bid.

“If the public-sector company matches the bid in that case the state will be divided in two equal zones, and one will be given to the private player,” he added.

An industry expert, however, said that states will find it difficult to operate in a trust mode as the state government will rely on third party administrators, which will have no accountability to prevent frauds or stop leakages.

  • Related Posts

    • Policy
    • February 10, 2023
    • 23 views
    DCGI serves showcase Notices to illegal E-Pharmacies selling medicines on Internet

    Kailash sharma:- AIOCD was constantly alarming Central Government that, Drug Acts, Pharmacy Act, & Other drugs related rules / orders, code of ethics, do not permit sale of medicines on…

    • Policy
    • June 25, 2022
    • 30 views
    Calcutta HC directs videography in cases of seizure related to narcotics

    New Delhi: The Calcutta high court has recently passed an order that said that officers seizing narcotics have to ascertain that narcotic drugs entire seizure procedure should be videographed. Reasoning that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

    Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

    Organovo’s Drug Significantly Reduces Liver Fat In NASH Study

    Organovo’s Drug Significantly Reduces Liver Fat In NASH Study